Medical Devices News and Research

RSS

Cardima implements reverse stock split

Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation and manufacturer of the Cardima Surgical Ablation System, announced today that its common stock will commence trading under the new ticker symbol, "CADMD" following the implementation of a reverse stock split in a 1-for-10 ratio.

11 May 2010

Alphatec Spine reports 25.6% increase in first-quarter 2010 revenue

Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today financial results for the first quarter March 31, 2010.

11 May 2010

Study results of CTT's Calmare Pain Therapy for CIPN to be presented

Competitive Technologies, Inc. announced today that Thomas J. Smith, M.D., Endowed Chair of Palliative Care Research and Medical Director of the Thomas Palliative Care Unit Virginia Commonwealth University's Massey Cancer Center, will present results of his study evaluating the treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTT's Calmare® Pain Therapy Treatment.

10 May 2010

Bovie Medical first-quarter revenues decrease to $5.6M

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2010.

10 May 2010

St. Jude Medical introduces Wireless USB Adaptor for Merlin@home transmitter in the U.S.

St. Jude Medical, Inc., a global medical device company, today announced the U.S. launch of its Wireless USB Adaptor for the Merlin@home™ transmitter, a system that allows important patient data from an implantable cardiac device to be wirelessly downloaded and securely transmitted via telephone for review by a physician. The new Wireless USB Adaptor enables patients using a Merlin@home transmitter to transmit data to their physician over cellular networks, allowing for more convenient care than existing landline services provide.

10 May 2010

Cytori Therapeutics to initiate European medical device approval study for Celution System

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells for the treatment of heart attacks showed a substantial reduction in the size of injury to the heart, an improvement in the amount of blood supply to the heart muscle, and a corresponding functional improvement in the amount of blood the heart can pump.

7 May 2010

USPTO grants patent for Quick-Med's proprietary NIMBUS polymeric antimicrobial technology

Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, today announced that it has been granted U.S. Patent No. 7,709,694 from the United States Patent and Trademark Office. The patent for company's proprietary NIMBUS polymeric antimicrobial technology is applicable to a variety of base materials including woven and nonwoven fabrics.

7 May 2010

HTRN's revenue for fourth-quarter 2009 totaled $50.3M: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring HealthTronics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

7 May 2010

Medtronic initiates U.S. clinical trial of RestoreSensor neurostimulator in chronic pain patients

Medtronic, Inc. today announced the initiation of a prospective, multi-center, randomized U.S. clinical trial for the RestoreSensorTM neurostimulator that adapts therapy to the changing needs of chronic pain patients by responding automatically to changes in body position and activity in an upright position.

7 May 2010

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

6 May 2010

Public need to be informed of nanotechnology's risks as well as benefits: Survey

A new national survey on public attitudes toward medical applications and physical enhancements that rely on nanotechnology shows that support for the technology increases when the public is informed of the technology's risks as well as its benefits - at least among those people who have heard of nanotechnology.

6 May 2010

NanoString Technologies receives ISO 13485:2003 certification

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices.

From NanoString Technologies 6 May 2010

AGA Medical first-quarter net sales increase 15.4% to $51.3 million

AGA Medical Holdings, Inc., a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular abnormalities, today reported financial results for the first quarter ended March 31, 2010.

6 May 2010

PTNS performed using Urgent PC Neuromodulation System to receive category 1 CPT reimbursement code

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that it has been informed that percutaneous tibial nerve stimulation (PTNS), the procedure performed using the Uroplasty Urgent PC Neuromodulation System, will receive a category 1 CPT reimbursement code. This is expected to occur when those codes are published by the Centers for Medicare and Medicaid Services, which is expected in October 2010.

6 May 2010

Home-based medical devices to grow over 1.6M by 2013: Report

Emerging Healthcare Solutions, Inc. applauded the results of a new report from InMedica on the world market for telemedicine, predicting that the use of home-based medical devices will drastically increase as telemedicine takes-off. According to the report, by 2013 the combined unit shipments of home-use digital blood-glucose meters, blood pressure monitors, weight scales, pulse oximeters and peak flow meters used in telemedical applications will grow to over 1.6 million.

6 May 2010

CSI fiscal third-quarter revenue increases 9% to $16.5 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2010.

6 May 2010

Home Diagnostics, Cellnovo announce strategic business deal

Building on a shared vision to simplify diabetes management worldwide, Cellnovo, a London-based medical device company, and Home Diagnostics, Inc., a leader in diabetes products, today announced a strategic alliance that involves integrating technologies and developing distribution opportunities for Cellnovo's insulin patch pumps.

6 May 2010

United BioSource Corporation acquires Abt Bio-Pharma Solutions

Abt Associates announced today the sale of its wholly-owned subsidiary Abt Bio-Pharma Solutions, Inc. to United BioSource Corporation, a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies.

6 May 2010

New breakthrough: Seaweed for treatment of swine flu

In a groundbreaking new discovery a Tasmanian company has used seaweed as treatment for swine flu. The lab trials have been going on for the past nine months using the undaria seaweed (better know as wakame seaweed) harvested from waters at Triabunna, of Tasmania's East Coast.

5 May 2010

TearScience completes $44.5 million Series C funding

TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.

5 May 2010